IDM PHARMA, INC. (IDMI) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 29 transactions totaling $1.1M, demonstrating a bearish sentiment with -$1.1M in net insider flow. The most recent transaction on Sep 23, 2009 involved a transaction of 2,931,029 shares valued at $7.7M.
No significant insider buying has been recorded for IDMI in the recent period.
No significant insider selling has been recorded for IDMI in the recent period.
Based on recent SEC filings, insider sentiment for IDMI is bearish with an Insider Alignment Score of 0/100 and a net flow of -$1.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IDM PHARMA, INC. (IDMI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading IDMI stock, having executed 29 transactions in the past 90 days. The most active insider is Alto Healthcare Master Fund, L.p. Palo (Executive), who has made 3 transactions totaling $8.8M.
Get notified when executives and directors at IDMI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 23, 2009 | Healthcare Master Fund, L.p. Palo Alto | Executive | Tender | 2,931,029 | $2.64 | $7.7M | Large |
| Sep 23, 2009 | Healthcare Fund, L.p. Palo Alto | Executive | Tender | 2,931,029 | $2.64 | $7.7M | Large |
| Apr 1, 2009 | Healthcare Master Fund, L.p. Palo Alto | Executive | Sale | 54,000 | $1.77 | $95.6K | |
| Apr 1, 2009 | Healthcare Master Fund, L.p. Palo Alto | Executive | Sale | 540,000 | $1.77 | $955.8K | Large |
| Dec 31, 2007 | Sanofi-aventis | Executive | Other | 0 | $N/A | $0 | |
| Nov 6, 2007 | John Wodar David | Executive | Gift | 100,000 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Award | 1,829 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Other | 456,506 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Other | 260,708 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Other | 15,987 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Other | 17,206 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Other | 43,567 | $N/A | $0 | |
| May 21, 2007 | Penhoet Edward | Executive | Other | 648,718 | $N/A | $0 | |
| May 21, 2007 | Deleage Jean | Executive | Other | 15,987 | $N/A | $0 | |
| May 21, 2007 | Deleage Jean | Executive | Other | 260,708 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 2 | $15.5M | 79.3% |
Award(A) | 11 | $3.0M | 15.3% |
Sale(S) | 2 | $1.1M | 5.4% |
Other(J) | 13 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at IDM PHARMA, INC. has increased, with 9 insiders executing 29 transactions across all time. Total sales of $1.1M significantly outpace purchases of $0, resulting in a net outflow of $1.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.